The European Virus Archive goes global: A growing resource for research

Autor: P. Lieutaud, M. Eropkin, X. de Lamballerie, Jan Felix Drexler, Z. Hu, Boris Klempa, Daniel D. Pinschewer, Hervé Raoul, Chantal Reusken, Thomas Klimkait, Andreas Nitsche, M. Bardsley, Antonino DiCaro, Jean-Louis Romette, Rémi N. Charrel, F. Pradel, Zverev Vv, Anthony R. Fooks, Ali Mirazimi, Giuseppe Ippolito, Sven Reiche, Thomas C. Mettenleiter, Stephan Günther, C. Sabeta, Marion Koopmans, Michael C. Carroll, Janusz T. Paweska, Ernest A. Gould, Hervé Bourhy, C. Prat, Tatjana Avsic-Zupanc, S. Mac Cullough, Alexander E. Gorbalenya, Maria Rosaria Capobianchi, Bruno Coutard, Christian Drosten, Carrie Batten
Přispěvatelé: Unité des Virus Emergents (UVE), Institut de Recherche pour le Développement (IRD)-Aix Marseille Université (AMU)-Institut National de la Santé et de la Recherche Médicale (INSERM), Architecture et fonction des macromolécules biologiques (AFMB), Institut National de la Recherche Agronomique (INRA)-Aix Marseille Université (AMU)-Centre National de la Recherche Scientifique (CNRS), Animal and Plant Health Agency [Weybridge] (APHA), Department of Health-Special Pathogens Laboratory, Charité - Universitätsmedizin Berlin / Charite - University Medicine Berlin, Bernhard Nocht Institute for Tropical Medicine, National Reference Center for tropical Infectious Diseases, Slovak Academy of Science [Bratislava] (SAS), University of Basel (Unibas), Institute of Microbiology and Immunology, Lubljana, Slovenia, Istituto Nazionale di Malattie Infettive 'Lazzaro Spallanzani' (INMI), Robert Koch Institute [Berlin] (RKI), Erasmus University Medical Center [Rotterdam] (Erasmus MC), Leiden University Medical Center (LUMC), Laboratoire P4 - Jean Mérieux, Centre Européen de Virologie/Immunologie-Institut National de la Santé et de la Recherche Médicale (INSERM), Institut Pasteur [Paris], Friedrich-Loeffler-Institut (FLI), The Pirbright Institute, Onderstepoort Veterinary Institute (ARC - OVI), National Institute for Communicable Diseases (NICD), Research Institute of Influenza, St. Petersburg, Russia, Mechnikov Scientific Research Institute for Vaccines and Sera, Moscow, Russia, Wuhan Institute of Virology, Australian Animal Health Laboratory (AAHL), Health and Biosecurity CSIRO, Geelong, Australia (AAHL, CSIRO), Folkhalsomyndigheten, Stockholm, Sweden, Fondation Mérieux, This publication was supported by the European Virus Archive global (EVAg) project that has received funding from the European Union's Horizon 2020 research and innovation programme under grant agreement No 653316., We wish to thank the following scientists for their expertise and contributions during the successful establishment and development of the EVAg: C. Barontia, L. McElhinneyc, D. Marstonc, L. Thornec, R. Hewsond, T. Bleickere, T. Riegerf, M. Korvai, N. Knapi, S. Meschij, P. Jansen van Vurenl, B. Phahladiral, C. Carbonellen, S. Carpenterq, A. Nikonovau, F. Dengv, N. Romanenkova1, S. Becker2, M. Saijo3, G. Gao Fu4, A. Lukashev5, E. Koray6 1 St Petersburg Pasteur Institute, St Petersburg, Russia 2 Institut für Virologie (UMR-DE), Marburg, Germany 3 National Institute of Infectious Diseases (NIID), Tokyo, Japan 4 China CDC, Beijing, China 5 Chumakov institute of Poliomyelitis and viral Encephalitides (IPVE), Moscow, Russia, 6 Hacettepe University, Faculty of Medicine (HU), Ankara, Turkey, European Project: 653316,H2020,H2020-INFRAIA-2014-2015,EVAg(2015), Centre National de la Recherche Scientifique (CNRS)-Aix Marseille Université (AMU)-Institut National de la Recherche Agronomique (INRA), Charité - UniversitätsMedizin = Charité - University Hospital [Berlin], Bernhard Nocht Institute for Tropical Medicine - Bernhard-Nocht-Institut für Tropenmedizin [Hamburg, Germany] (BNITM), National Institute for Communicable Diseases [Johannesburg] (NICD), Universiteit Leiden, Institut Pasteur [Paris] (IP), Virology
Jazyk: angličtina
Rok vydání: 2018
Předmět:
Zdroj: Antiviral Research
Antiviral Research, Elsevier Masson, 2018, 158, pp.127-134. ⟨10.1016/j.antiviral.2018.07.017⟩
Antiviral Research, 2018, 158, pp.127-134. ⟨10.1016/j.antiviral.2018.07.017⟩
Antiviral Research, 158, 127-134
Antiviral Research, 158, 127-134. Elsevier
ISSN: 0166-3542
DOI: 10.1016/j.antiviral.2018.07.017⟩
Popis: The European Virus Archive (EVA) was created in 2008 with funding from the FP7-EU Infrastructure Programme, in response to the need for a coordinated and readily accessible collection of viruses that could be made available to academia, public health organisations and industry. Within three years, it developed from a consortium of nine European laboratories to encompass associated partners in Africa, Russia, China, Turkey, Germany and Italy. In 2014, the H2020 Research and Innovation Framework Programme (INFRAS projects) provided support for the transformation of the EVA from a European to a global organization (EVAg). The EVAg now operates as a non-profit consortium, with 26 partners and 20 associated partners from 21 EU and non-EU countries. In this paper, we outline the structure, management and goals of the EVAg, to bring to the attention of researchers the wealth of products it can provide and to illustrate how end-users can gain access to these resources. Organisations or individuals who would like to be considered as contributors are invited to contact the EVAg coordinator, Jean-Louis Romette, at jean-louis.romette@univmed.fr.
Highlights • The EVAg was created as an international organization aiming to provide a gold standard resource to the scientific community. • The EVAg operates as a non-profit consortium of 26 partners and 20 associated partners from EU and non-EU countries. • Members and associated members retain ownership of the viruses that they disseminate via the EVAg infrastructure. • The EVAg approach to quality management is directed by the project's own quality standard, based upon OECD guidelines. • The ultimate objective is to make the EVAg a permanent archive that can provide access to viruses and reagents globally.
Databáze: OpenAIRE
Externí odkaz: